GYRE THERAPEUTICS INC (GYRE) Stock Cash Flow
NASDAQ:GYRE - Nasdaq - US4037831033 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -64.35M | -85.48M | -8.20M | -87.90M | -56.20M | |||
| Depreciation Amortization | 2.16M | 1.07M | 200.00K | 300.00K | 100.00K | |||
| Income Taxes - Deferred | N/A | -1.16M | N/A | N/A | N/A | |||
| Change In Working Capital | -2.22M | 6.83M | -4.90M | 500.00K | -2.60M | |||
| Other non cash items | 102.89M | 104.63M | -20.10M | 3.40M | 3.60M | |||
| OPERATING CASH FLOW | 36.91M | 25.89M | -33.10M | -83.80M | -55.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -8.59M | 0.00 | -800.00K | -300.00K | |||
| Other Investing Activity | -31.87M | -11.17M | 55.40M | 49.00M | 9.90M | |||
| INVESTING CASH FLOW | -42.84M | -19.76M | 55.40M | 48.20M | 9.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 3.81M | 2.50M | 0.00 | 49.60M | 60.40M | |||
| Dividend Paid | N/A | N/A | -45.00M | N/A | N/A | |||
| FINANCING CASH FLOW | 16.34M | 2.50M | -45.00M | 49.60M | 60.40M | |||
| Exchange Rate Effect | N/A | -298.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | 10.09M | 8.33M | -22.70M | 14.00M | 15.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 36.91M | 25.89M | -33.10M | -83.80M | -55.00M | |||
| Capital Expenditure | N/A | -8.59M | 0.00 | -800.00K | -300.00K | |||
| FREE CASH FLOW | 25.94M | 17.31M | -33.10M | -84.60M | -55.30M | |||
All data in USD